Production (Stage)
Exagen Inc.
XGN
$6.60
$0.579.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.78% | 5.89% | 8.00% | 7.05% | 20.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.78% | 5.89% | 8.00% | 7.05% | 20.12% |
| Cost of Revenue | 0.45% | -2.44% | -3.41% | -3.85% | -5.51% |
| Gross Profit | 2.71% | 12.41% | 17.75% | 16.14% | 48.35% |
| SG&A Expenses | -8.79% | -12.77% | -9.66% | -12.21% | -10.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.26% | -8.10% | -8.66% | -11.58% | -12.66% |
| Operating Income | 22.81% | 40.29% | 41.40% | 45.55% | 52.50% |
| Income Before Tax | 19.83% | 36.16% | 48.42% | 51.23% | 57.13% |
| Income Tax Expenses | -63.64% | -63.64% | 111.70% | 111.70% | 111.70% |
| Earnings from Continuing Operations | 19.91% | 36.19% | 47.87% | 50.74% | 56.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.91% | 36.19% | 47.87% | 50.74% | 56.79% |
| EBIT | 22.81% | 40.29% | 41.40% | 45.55% | 52.50% |
| EBITDA | 23.47% | 42.37% | 43.63% | 48.88% | 55.81% |
| EPS Basic | 22.46% | 38.12% | 49.65% | 52.30% | 58.20% |
| Normalized Basic EPS | 22.39% | 38.08% | 39.07% | 43.26% | 52.29% |
| EPS Diluted | 22.46% | 38.12% | 49.65% | 52.30% | 58.20% |
| Normalized Diluted EPS | 22.39% | 38.08% | 39.07% | 43.26% | 52.29% |
| Average Basic Shares Outstanding | 3.22% | 2.96% | 3.06% | 3.16% | 3.29% |
| Average Diluted Shares Outstanding | 3.22% | 2.96% | 3.06% | 3.16% | 3.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |